Gentium Investors Sue Over $1B Jazz Pharma Deal
Italy-based biopharmaceutical firm Gentium SpA and its suitor Jazz Pharmaceuticals Public Limited Co. were hit with a proposed class action in New York federal court Wednesday by Gentium shareholders claiming the...To view the full article, register now.
Already a subscriber? Click here to view full article